-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Merck & Co, Lowers Price Target to $145

Benzinga·05/01/2026 13:47:51
Listen to the news
Wells Fargo analyst Mohit Bansal maintains Merck & Co (NYSE:MRK) with a Overweight and lowers the price target from $150 to $145.